Bentall procedure using cryopreserved valved aortic homografts: mid- to long-term results.
The Bentall procedure is the standard operation for patients who have lesions of the ascending aorta associated with aortic valve disease. In many cases, however, mechanical prosthetic conduits are not suitable. There are few reports in the English-language medical literature concerning the mid- to long-term outcome of Bentall operations with cryopreserved homografts. Therefore, we reviewed our experience with this procedure and valved homografts. From January 1997 through December 2002, 21 patients underwent a Bentall operation with cryopreserved homografts at our institution. There were 14 males and 7 females; the mean age was 36 +/- 21 years (range, 15-74 years). Eleven patients had undergone previous aortic valve surgery. All patients had aortic dilatation or aneurysms involving the ascending aorta. Indications for surgery included aortic valve stenosis or insufficiency, and aortic valve endocarditis (native valve or prosthetic). One patient had Takayasu's arteritis and 3 had Marfan syndrome. There was 1 hospital death (due to sepsis), but no other major postoperative complications. The mean hospital stay was 14 +/- 7 days. Follow-up echocardiographic and computed tomographic scans were performed yearly. The mean follow-up was 34 months (6-72 months). Follow-up imaging revealed no calcifications or degenerative processes related to the homograft. Four patients had minimal valve regurgitation. Two patients died during follow-up. The 3-year actuarial survival rate was 85.7%. Our data suggest that the Bentall procedure with a valved homograft conduit is a safe procedure with excellent mid- to long-term results, comparable to results reported with aortic valve replacement with a homograft.
Christenson
Jan T
JT
Department of Cardiovascular Surgery, University Hospital of Geneva, CH-1211 Geneva 14, Switzerland. jan.christenson@hcuge.ch
Sierra
Jorge
J
Trindade
Pedro T
PT
Dominique
Didier
D
Kalangos
Afksendiyos
A
D000293:Adolescent; D000328:Adult; D000368:Aged; D001011:Aorta / Q000601:surgery*; D001014:Aortic Aneurysm / Q000150:complications / Q000601:surgery*; D001021:Aortic Valve / Q000637:transplantation*; D019917:Blood Vessel Prosthesis Implantation / Q000379:methods*; D015925:Cryopreservation; D005260:Female; D005500:Follow-Up Studies; D006349:Heart Valve Diseases / Q000150:complications / Q000601:surgery*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D016896:Treatment Outcome
Tex Heart Inst J. 2000;27(4):366-8
11198310
Ann Thorac Surg. 1998 Jul;66(1):88-91
9692444
J Heart Valve Dis. 2001 Sep;10(5):650-5
11603605
Eur J Cardiothorac Surg. 2002 Feb;21(2):260-7
11825733
Ann Thorac Surg. 2002 Feb;73(2):438-43
11845856
Asian Cardiovasc Thorac Ann. 2002 Jun;10(2):97-100
12079928
Thorac Cardiovasc Surg. 1981 Aug;29(4):195-9
6179184
J Thorac Cardiovasc Surg. 1987 Mar;93(3):366-74
3821146
J Thorac Cardiovasc Surg. 1988 Apr;95(4):696-704
3352305
Thorac Cardiovasc Surg. 1991 Jun;39(3):117-22
1882374
Ann Thorac Surg. 1991 Sep;52(3):669-73; discussion 673-5
1898171
J Thorac Cardiovasc Surg. 1993 Jul;106(1):154-65; discussion 165-6
8320994
J Thorac Cardiovasc Surg. 1994 Jun;107(6):1540-1
8196407
J Thorac Cardiovasc Surg. 1995 Mar;109(3):536-44; discussion 544-5
7877316
J Thorac Cardiovasc Surg. 1995 Jul;110(1):186-93; discussion 193-4
7609543
Ann Thorac Surg. 1995 Aug;60(2 Suppl):S65-70
7646213
Eur J Cardiothorac Surg. 1995;9(9):531-3
8800705
Ann Thorac Surg. 1997 Sep;64(3):659-63; discussion 663-4
9307453
Tex Heart Inst J. 1998;25(1):68-71
9566067
Eur J Cardiothorac Surg. 2001 Oct;20(4):835-41
11574234